India is positioning itself as a formidable force in the global healthcare arena, a strategic vision underscored by the ambitious initiatives unveiled in the Union Budget 2026-27. Finance Minister Nirmala Sitharaman’s proposals are designed to fundamentally transform the nation’s health infrastructure, encompassing the establishment of five regional medical tourism hubs, a substantial Rs 10,000-crore Biopharma Shakti program spanning five years, and the creation of three new All India Institutes of Ayurveda. These measures collectively signal a robust commitment to enhancing India’s standing as a premier healthcare destination, attracting international patients, and fostering domestic innovation.
Elevating India’s Medical Tourism Landscape
During her address in Parliament, Minister Sitharaman articulated a clear strategy for bolstering India’s appeal for patient travel, stating, “I propose to launch a scheme to support states in establishing five regional medical hubs.” These forthcoming hubs are envisioned as comprehensive, integrated healthcare complexes. They are designed to seamlessly blend advanced medical facilities with educational and research capabilities, serving as a beacon for cross-border healthcare. Each hub will feature dedicated AYUSH centers, specialized medical value tourism facilitation centers, and robust infrastructure for diagnostics, post-care, and rehabilitation services.
From an industry perspective, these regional centers are poised to generate significant and diverse employment opportunities for medical professionals, including doctors and allied health professionals (AHPs). This expansion of skilled human capital is crucial for strengthening the quality of care and India’s competitive edge in the global medical tourism market. The holistic nature of these hubs, combining various facets of healthcare delivery and support, is expected to streamline the patient journey for international patients, making India an even more attractive healthcare destination.
Fortifying Domestic Biopharma Capabilities
Further demonstrating a commitment to self-reliance and innovation in healthcare, Minister Sitharaman elaborated on the Biopharma Shakti program. She announced, “I propose the Biopharma Shakti with an outlay of Rs 10,000 crore over the next five years. This will build the ecosystem for domestic production of biologics and biosimilars.” This substantial investment is aimed at cultivating a robust domestic ecosystem for the production of cutting-edge biologics and biosimilars, critical components in modern medicine.
This strategic initiative includes a significant expansion of India’s pharmaceutical research and development infrastructure. The plan involves establishing three new National Institutes of Pharmaceutical Education and Research (NIPERS) and upgrading seven existing NIPERS, creating a formidable biopharma-focused network. Moreover, a key component is the development of a network comprising “1,000 accredited Indian clinical trials sites,” as she added. To ensure these advancements meet global healthcare standards, the Finance Minister also indicated a critical upgrade for regulatory oversight: “We propose to strengthen the central drug standard control organisation to meet global standards and approve time frames, through an approval time frames through a dedicated scientific review cadre, and specialists.” This move is essential for ensuring the quality of care and accelerating market access for new pharmaceutical products, ultimately benefiting both domestic and international patient care.
The Resurgence of Traditional Medicine and Wellness Tourism
Beyond conventional medicine, the Union Budget places a significant emphasis on advancing India’s rich heritage in traditional medicine. A major push for Ayurveda was announced, capitalizing on its heightened global acceptance following the COVID-19 pandemic. This initiative aims to boost exports of Ayurvedic products, provide essential support to herb-growing farmers, and create new job opportunities for young people in processing sectors. Minister Sitharaman observed to Parliament, “Post-COVID, Ayurveda gained similar global acceptance,” outlining targeted measures to address the increasing international demand:
- Establishment of three new all-India institutes of Ayurveda: These institutions will serve as centers of excellence for research, education, and clinical practice in Ayurveda.
- Upgrading AYUSH pharmacies and drug testing labs: This will ensure adherence to top-tier certification standards, bolstering confidence in traditional medicine products.
- Enhancing the WHO Global Traditional Medicine Centre in Jamnagar: This move solidifies India’s role as a global leader in traditional medicine research and development.
These strategic enhancements are designed to drive evidence-based research, promote advanced training, and elevate global awareness for traditional medicine. This comprehensive approach is instrumental in strengthening India’s position as a leading wellness tourism hub and a significant exporter of wellness-related services and products, attracting international patients seeking holistic health solutions.
Integrating Agriculture for a Holistic Health Ecosystem
The government’s health initiatives are intricately linked with broader agricultural reforms, particularly through the Bharat Vistar AI tool. This synergy is designed to benefit India’s rural economies, where a substantial 46.1% of the workforce is engaged in farming (PLFS 2023-24), by effectively connecting herbal cultivation to global markets. The invigorated focus on Ayurveda is significantly bolstered by the Bharat Vistar system, which empowers farmers cultivating medicinal herbs—those crucial for post-COVID global exports—with access to tailored AI-driven advisories on optimal cultivation practices, productivity enhancements, and market insights.
Bharat Vistar achieves this by integrating data from AgriStack and ICAR, delivering customized guidance on crops, soil conditions, and potential risks, all in local languages. This sophisticated system can now extend its reach to high-value Ayurvedic herbs, directly supporting the steps introduced to meet the burgeoning international demands for Ayurveda. For herb farmers, this translates into AI-powered recommendations for ideal planting schedules, effective pest control strategies, and methods to maximize yields for valuable AYUSH crops such as coconut and sandalwood. This direct linkage not only fuels exports and creates youth processing jobs but also significantly boosts rural incomes, fostering a holistic and sustainable health ecosystem.
Bottom Line: India’s Vision for Global Healthcare Leadership
The Union Budget 2026-27 outlines a clear and ambitious trajectory for India’s healthcare sector. The combined impact of these initiatives is poised to redefine India’s role as a global healthcare provider and innovator.
- Enhanced Healthcare Destination Status: The regional medical tourism hubs will solidify India’s position as a preferred choice for international patients seeking quality of care and diverse treatment options, including wellness tourism.
- Self-Reliance in Biopharma: The Biopharma Shakti program, coupled with NIPERS expansion and regulatory strengthening, will foster domestic production of essential medicines, impacting patient travel costs and improving access to cutting-edge treatments.
- Global Leadership in Traditional Medicine: The significant investment in Ayurveda and the WHO Global Traditional Medicine Centre in Jamnagar will elevate India’s standing as a hub for evidence-based traditional medicine and wellness exports.
- Economic Empowerment: The integration of agricultural reforms through Bharat Vistar will create a synergistic ecosystem, linking rural economies to global health markets and generating jobs and incomes.
These strategic investments underscore India’s commitment to not only serving its own population but also to becoming a pivotal player in global healthcare, offering advanced, accessible, and integrated medical and wellness solutions to the world.
The news signal for this article was referred from: https://timesofindia.indiatociom/business/india-business/union-budget-2026-5-regional-medical-tourism-hubs-to-be-set-up/articleshow/127835512.cms